Carbuncle Treatment Market Forecast Size will Observe Substantial Growth by 2027

Carbuncle Treatment Market: Introduction

Carbuncle is a bacterial infection that infects the hair follicles on skin. It is primarily caused by bacteria Staphylococcus aureus. Scrapes, broken skin, and moist parts of the body are the favorable conditions for carbuncle infection.
Carbuncle usually develops on the back of the neck, shoulders, on thighs, armpits, buttocks, and any part of the body that tends to sweat. It causes red, painful, and swollen skin at the site of infection. It can spread up to 2 inches to 5 inches long and is more likely to leave a scar.
People with diabetes, dermatitis, kidney & liver diseases, and patients with poor immune system are more susceptible to carbuncle
Treatment of carbuncle depends on various factors such as size, location, and the duration for which the infection was left untreated
Carbuncle can be treated with home remedies, antibiotics, pain relievers, and antibacterial soaps. In severe cases, surgery is advised if carbuncle does not respond to medical treatments.

Global Carbuncle Treatment Market: Key Drivers

The global carbuncle treatment market is primarily driven by high prevalence and increase in incidence rates of carbuncle infection across the globe
Diabetic patients and patients with kidney disorders & other skin diseases are more susceptible to carbuncle. Large patient pool with diabetes, kidney disorders, and dermatological diseases is projected to boost the growth of the global market during the forecast period.
Promising product pipeline for the treatment of carbuncle and launch & commercialization of new products is anticipated to contribute to the growth of the global carbuncle treatment market from 2019 to 2027

Cephalosporin Segment to Dominate Global Market

In terms of drug class, the global carbuncle treatment market can be classified into cephalosporin, lincomycin, tetracycline, and others. The cephalosporin segment is expected to dominate the global market during the forecast period.
Cephalosporin drugs are used as first-line treatment of carbuncle. Easy availability of cephalosporin, low cost, and rise in adoption are likely to fuel the growth of the segment from 2019 to 2027.

Topical Segment to Offer Attractive Opportunity

In terms of route of administration, the global carbuncle treatment market can be categorized into topical, oral, and intravenous. The topical segment is projected to dominate the global carbuncle treatment market during the forecast period.
Topical gels and creams are the most common forms of antibiotics prescribed for the treatment of carbuncle

Retail Pharmacies to be Lucrative Segment

Based on distribution channel, the global carbuncle treatment market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment is projected to dominate the global market during the forecast period.
Easy availability of antibiotics at the over-the-counter stores and preference for retail pharmacy stores for OTC drugs are projected to drive the segment from 2019 to 2027

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Carbuncle Treatment Market Report